Stockscreener 앱 받기
3.15
5.26%
-0.175
시간 외 거래:
3.15
전일 마감가:
$3.325
열려 있는:
$3.28
하루 거래량:
377.85K
Relative Volume:
4.81
시가총액:
$50.08M
수익:
-
순이익/손실:
$-23.87M
주가수익비율:
-0.1601
EPS:
-19.67
순현금흐름:
$-47.63M
1주 성능:
-10.00%
1개월 성능:
-8.70%
6개월 성능:
+28.57%
1년 성능:
-10.26%
1일 변동 폭
$3.06
$3.405
1주일 범위
$3.06
$3.56
52주 변동 폭
$2.30
$3.93
폴리피드 Stock (PYPD) Company Profile
PYPD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PYPD
Polypid Ltd
|
3.15 | 52.86M | 0 | -23.87M | -47.63M | -19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
폴리피드 Stock (PYPD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-05 | 개시 | Roth Capital | Buy |
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2021-09-14 | 개시 | JMP Securities | Mkt Outperform |
| 2021-07-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-24 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-10 | 개시 | Alliance Global Partners | Buy |
| 2020-07-21 | 개시 | BMO Capital Markets | Outperform |
| 2020-07-21 | 개시 | Barclays | Overweight |
| 2020-07-21 | 개시 | Raymond James | Outperform |
모두보기
폴리피드 주식(PYPD)의 최신 뉴스
Weiss Ratings Reaffirms Sell (E+) Rating for PolyPid (NASDAQ:PYPD) - MarketBeat
Analyzing recovery setups for PolyPid Ltd. investors2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Is this a good reentry point in PolyPid Ltd.2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
Best data tools to analyze PolyPid Ltd. stockMarket Growth Report & Free Long-Term Investment Growth Plans - newser.com
PolyPid Ltd. (NASDAQ:PYPD) Sees Large Increase in Short Interest - Defense World
PolyPid Ltd. (NASDAQ:PYPD) Short Interest Update - MarketBeat
Price action breakdown for PolyPid Ltd.July 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Will PolyPid Ltd. see short term momentumBuy Signal & Stock Portfolio Risk Management - newser.com
Tools to monitor PolyPid Ltd. recovery probabilityBreakout Watch & Safe Capital Investment Plans - newser.com
Is PolyPid Ltd a good long term investmentMid Cap Growth Trends & Achieve Consistent Profits - earlytimes.in
PolyPid to present phase 3 SHIELD II trial results at ACS congress - Investing.com Nigeria
PolyPid at Lytham Partners: Strategic Insights on D-PLEX100 By Investing.com - Investing.com Australia
PolyPid at Lytham Partners: Strategic Insights on D-PLEX100 - Investing.com India
PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress - The Manila Times
PolyPid Ltd. Announces Presentation of Phase 3 SHIELD II Trial Results at 2025 ACS Clinical Congress - Quiver Quantitative
PolyPid to Present Its Positive Phase 3 SHIELD II Topline - GlobeNewswire
PolyPid (NASDAQ:PYPD) & Cronos Group (NASDAQ:CRON) Head to Head Survey - Defense World
What analysts say about PolyPid Ltd stockVolume Analysis Techniques & Invest Smarter With Data-Driven Models - earlytimes.in
What drives PolyPid Ltd stock priceFibonacci Retracement Levels & Free Rapid Growing Investment Returns - earlytimes.in
PolyPid Ltd. (NASDAQ:PYPD) Receives $12.40 Consensus PT from Analysts - Defense World
PolyPid (NASDAQ:PYPD) Rating Increased to Hold at Wall Street Zen - MarketBeat
What to expect from PolyPid Ltd. in the next 30 days2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
PolyPid Ltd. (NASDAQ:PYPD) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
PolyPid (NASDAQ:PYPD) Stock Price Up 2.9%Time to Buy? - MarketBeat
PolyPid (NASDAQ:PYPD) Stock Price Up 2.9% – Time to Buy? - Defense World
Will a bounce in PolyPid Ltd. offer an exitBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
Multi factor analysis applied to PolyPid Ltd.Exit Point & Verified High Yield Trade Plans - newser.com
Real time breakdown of PolyPid Ltd. stock performanceMarket Rally & AI Driven Price Predictions - newser.com
Does PolyPid Ltd. show high probability of reboundExit Point & Safe Entry Trade Signal Reports - newser.com
Strategies to average down on PolyPid Ltd.July 2025 Decliners & Weekly High Potential Stock Alerts - newser.com
PolyPid completes Israeli Ministry of Health GMP inspection - MSN
PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements - msn.com
Is PolyPid Ltd. forming a reversal patternRisk Management & Weekly High Return Stock Opportunities - newser.com
Decliners Report: Can PolyPid Ltd. ride the EV waveWeekly Market Report & Entry Point Strategy Guides - خودرو بانک
Applying Wyckoff theory to PolyPid Ltd. stockMarket Risk Summary & Proven Capital Preservation Methods - newser.com
Profit Review: Is now the right time to enter ATIIWJuly 2025 Pullbacks & Comprehensive Market Scan Insights - khodrobank.com
PolyPid Ltd. stock trendline breakdownJobs Report & Free Fast Entry Momentum Trade Alerts - newser.com
폴리피드 (PYPD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):